Terry Barnes Australia 

Terry Barnes is an Australian policy analyst, political commentator and currently Fellow of the UK Institute of Economic Affairs. He has written and spoken extensively on excessive health regulation in Australia, especially in relation to Tobacco Harm Reduction. He also advises THR advocates working to ensure the regulatory environment accepts and not rejects disruptive innovations including vaping.

Clive Bates UK  Debate 

Clive Bates has had a diverse career in the public, private and not-for-profit sectors. He started out with the IT company, IBM, then switched career to work in the environment movement. From 1997-2003 he was Director of Action on Smoking and Health (UK), campaigning to reduce the harms caused by tobacco. In 2003 he joined Prime Minister Blair’s Strategy Unit as a civil servant and worked in senior roles in the public sector and for the United Nations in Sudan. He is now Director of Counterfactual, a consulting and advocacy practice focussed on a pragmatic approach to sustainability and public health.

Greg Conley USA  PAP track 

Gregory Conley is the president of the American Vaping Association, a nonprofit organization that champions regulatory policies toward vapor products designed to maximize the effectiveness of vaping for quitting smoking. He is one of the most prominent defenders of vaping in the United States and has appeared on CNN, Fox News, and MSNBC. Mr Conley is also an attorney and a consultant on vaping legislative and regulatory issues. He began working on vaping issues in 2010 after quitting smoking with a vapor product while in law school. He served as the pro bono legislative director for the Consumer Advocates for Smoke-Free Alternatives Association from 2011 to 2014.

Sharon Cox UK 

Dr Sharon Cox has over ten years’ experience working in the drug and alcohol field, including working at front-line services with some of the UK’s most deprived communities. She has a special interest in harm reduction and the use of translational methodologies in vulnerable and marginalised groups. She currently works as a Trial Manager at London South Bank University’s Centre for Addictive Behaviours Research. Her current research is focused on e-cigarette puffing patterns associated with high and low nicotine e-liquid strength, smoking and alcohol consumption within disadvantaged groups and the impact of health warning labels on reduced risk products.

Abrie du Plessis South Africa 

Abrie du Plessis taught Law at the University of Stellenbosch, South Africa, before he joined a multinational company as an intellectual property practitioner. As part of several subsequent roles within the Tobacco Industry he spent more than a decade tracking the development of the WHO Framework Convention on Tobacco Control (FCTC). While based in Brussels he also followed the initial development of the 2014 Tobacco Products Directive. After retiring in 2013 he joined the South African Trade Law Centre (Tralac) as an Associate. He still follows FCTC developments and takes a special interest in the approach of the Convention towards novel and emerging nicotine products, most of which did not exist when its final text was agreed.

Konstantinos Farsalinos Greece  Science track 

Konstantinos E. Farsalinos, M.D., is a research fellow at the Onassis Cardiac Surgery Center in Athens-Greece, at the Department of Pharmacy, University of Patras-Greece and at the National School of Public Health-Greece. He has been conducting laboratory and clinical research on e-cigarettes as a principal investigator since 2011. Examples of his work include the first study on the cytotoxic effects of e-cigarette vapor on cultured cells and the immediate effects of e-cigarette use on cardiac function and coronary circulation. As of late 2019, he has published more than 80 studies and articles in international peer-reviewed scientific journals about tobacco harm reduction. He has been recognized as one of the world's most influential researchers of the past decade by Web of Science, receiving the Highly Cited Researcher 2019 recognition.

Marina Foltea Switzerland 

Dr Marina Foltea is founder and Managing Director at Trade Pacts, a trade and investment consultancy based in Geneva advising global companies and governmental institutions. Her main areas of expertise are international trade agreements and economic organisations, as well as public policy and affairs. She takes keen interest in the regulations and policy applicable to fast-moving consumer goods, in particular tobacco and e-cigarettes.

Marewa Glover New Zealand  Science track  

Marewa Glover is Director of the independent Centre of Research Excellence: Indigenous Sovereignty & Smoking based in Auckland, New Zealand but focused on tobacco use among all indigenous people globally. She is also Tobacco Section Editor for the international Harm Reduction Journal. She has led and collaborated on many studies resulting in over 100 scientific publications. Her dedication to reducing tobacco smoking harm over 25 years and advocating for a harm reduction approach to smoking was recognized with several awards. Marewa was appointed as an INNCO scientific advisor and is an associate member of the NNA UK. Marewa is a former Massey University Professor of Public Health and former Chair of End Smoking NZ.

Will Godfrey USA  PAP track 

Will Godfrey is the founding editor-in-chief of Filter (https://filtermag.org), an online magazine that launched in 2018 to cover drug use, drug policy and human rights through a harm reduction lens. He's also the executive director of The Influence Foundation, the nonprofit behind Filter. He previously founded The Influence, an award-winning drug policy news site, and ran Substance.com and the addiction-focused site The Fix. Before that, he co-founded an award-winning print publication for incarcerated people in London. He has consulted for numerous organisations in the drug policy and harm reduction space. He lives in New York.

Patricia Kovacevic USA  Parallel 2A 

A global legal and compliance nicotine, cannabis and CBD expert, and currently an independent consultant/principal at RegulationStrategy.com, Patricia Kovacevic’s experience comprises past General Counsel and Chief Compliance Officer roles at a leading nicotine/CBD multinational, and senior legal and regulatory positions at, among others, Philip Morris International and Lorillard. While at Lorillard, her team obtained the first ever premarket authorization for a tobacco product issued by the FDA under the Tobacco Control Act (2013). At Nicopure Labs she spearheaded the litigation against the FDA challenging the so-called “deeming rule”. Prior to joining Lorillard she was a partner at Patton Boggs. Her expertise includes global e-cigarette and tobacco regulation, cannabis regulation, compliance and all regulatory aspects of marketing/media communications,

David MacKintosh UK  Closing session 

David MacKintosh is the Head of Community Safety for the City of London, and has also been the Policy Adviser/Director to the London Drug and Alcohol Policy Forum (LDAPF) since 2001. He has been involved in a number of innovative campaigns around issues including drug driving, substance misuse in the workplace and improving awareness around drug safety in clubs and pubs. The LDAPF is funded by the City of London as part of its commitment to improving the life of all those who live and work in London. For the last eight years he has also been seconded to the Greater London Authority to provide advice around substance use issues and health inequalities.

Michael McGrady USA 

Michael McGrady is an accomplished independent public policy researcher and journalist based in Colorado, United States of America. He has an educational background in global politics from the University of Colorado, Colorado Springs. He is one of the youngest people ever to be featured in the editorial pages of The Wall Street Journal and The South China Morning Post. Other outlets that have published or cited his work include The Jerusalem Post, New York Post, The Spectator (U.K.), Spiked (U.K.), the Denver Post, the Washington Examiner, The Hill, and many others internationally. Currently, McGrady’s research and journalism has focused on the intersections of tobacco harm reduction and economics.

Ethan Nadelmann USA 

Ethan Nadelmann has played a leading role in harm reduction and other drug policy reform efforts in the United States and globally since the late 1980s. He was born in New York City, received his BA, JD, and PhD from Harvard, and taught politics and public affairs at Princeton University (1987-1994). He then founded first The Lindesmith Center (1994-2000, a drug policy institute created with the philanthropic support of George Soros) and then the Drug Policy Alliance (DPA), which he directed from 2000 until 2017. His TED Talk, “Why we need to end the drug war,” has over two million views.

Chimwemwe Ngoma Malawi  PAP track 

Chimwemwe Ngoma is a social scientist, tobacco harm reduction advocate and Project Manager for THR Malawi which is an information dissemination project on Tobacco Harm Reduction and Nicotine science in Malawi. Chimwemwe has worked as a Content Writer Consultant at Solimar International, he has also worked as a Project Officer at Drug Fight Malawi.

Caitlin Notley UK  Science track chair 

Dr Notley is a Senior Lecturer in Mental Health at the Norwich Medical School, University of East Anglia, and lead of the Addictions Research Group. She is a social scientist with extensive experience in all aspects of addiction research. Her current programme of research is focused on tobacco smoking relapse prevention, particularly working with vulnerable groups. Dr Notley’s research interests in alternative nicotine delivery devices primarily explores social and culturally pertinent aspects of vaping. Her work emphasises the public health potential of vaping for smoking relapse prevention, taking a ‘real world’ approach to highlight the importance of user focused perspectives on switching from traditional smoking to vaping.

Helen Redmond USA  Satellite 

Helen Redmond is an expert in substance use with over a decade of experience working with drug users and people with mental health problems. Her current focus is on helping smokers from vulnerable groups switch to e-cigarettes. At New York Harm Reduction Educators, Helen facilitates tobacco harm reduction/vaping groups. She is a senior editor at Filter and writes about vaping and creates short Op-Docs. Helen is adjunct faculty at the Silver School of Social Work at New York University.

Deborah Robson UK  PAP track 

Deborah Robson is a mental health nurse and researcher. Her current role involves the development, implementation and evaluation of tobacco dependence treatment initiatives for people with a mental health condition and/ or substance use disorder who smoke. She has developed online education courses and advanced skills training for treating tobacco dependence in mental health settings. Debbie is also involved in policy work e.g. she is a co-author of Public Health England commissioned reports about e-cigarettes and vaping.

Louise Ross UK  MRO 

Louise Ross managed the Leicester City (UK)Stop Smoking Service from 2004 to 2018. When vaping came along, she was initially sceptical, and was concerned about the risks and the problems it might bring. However, having met vapers at the first E-Cigarette Summit in London in 2013, she realised there was a huge potential benefit in embracing this new technology, and with her committed team rebranded themselves as the first ‘Ecig-friendly’ Stop Smoking Service. Since then she has celebrated the success of this initiative and vigorously challenges those who work against tobacco harm reduction.

Harry Shapiro UK  Satellite 

Harry Shapiro, DrugWise Director, has worked in the drugs field for over 35 years, most recently as Director of Communications for DrugScope. He was DrugScope’s main media spokesperson, managing editor of Druglink and has written extensively on all aspects of drugs and drug-related issues combining this with lecturing, public speaking and advisory work for government. He remains the managing editor of DS Daily.

Gerry Stimson UK  Programme chair 

Professor Gerry Stimson is a public health social scientist, with over 40 years’ experience of research and advocacy. He was one of the founders of drugs harm reduction in the 1980s and helped develop and evaluate harm reduction in the UK as a response to HIV/AIDS. He has advised the UK Government, WHO, UNAIDS, UNODC, World Bank and numerous governments on issues relating to drugs, HIV infection and AIDS, and alcohol. He is an advocate for tobacco harm reduction as a key public health strategy for reducing smoking related harms. He has published over 220 scientific publications and several books. He is Honorary Professor at the London School of Hygiene and Tropical Medicine, Emeritus Professor at Imperial College London.

Alex Wodak Australia  PAP track 

Dr Alex Wodak AM is a retired physician who is now President of the Australian Drug Law Reform Foundation. he works full time on drug law reform as a volunteer. Together with colleagues, he started the first needle syringe programme (1986) and the first medically supervised injecting centre (1999) in Australia when both were pre-legal. Dr Wodak was President of the International Harm Reduction Association (1996-2004). He has been interested in tobacco harm reduction since 1992 but only active in THR in recent years. Dr Wodak helped to start the National Drug and Alcohol Research Centre (1987).

Julie Woessner UK  Satellite 

Julie Woessner serves as President on INNCO’s Governing Board, thus representing the interests of thousands of nicotine consumers from all over the world. She is also the National Policy Director on the Board of Directors of CASAA (the Consumer Advocates for Smoke-free Alternatives Association). CASAA, a nonprofit U.S.-based public health and education nonprofit, advocates for people who consume, or might in the future consume, low-risk alternatives to cigarettes. CASAA engages in policy advocacy in the U.S. involving legislative and regulatory matters to protect access to low-risk products and mobilizes its 250,000+ members to do the same. Woessner holds a JD from Duke School of Law and was previously a practicing attorney.